HKSE:00874 (Hong Kong)
Â
Class H
HK$
21.10
(+2.18%)
Jun 24
New Key Statistics Module, Z-Score and F-Score
HKSE:00874 Key Ratios
Market Cap HK$ M | 49,536.42 |
Enterprise Value HK$ M | 43,839.46 |
P/E(ttm) | 7.70 |
PE Ratio without NRI | 7.62 |
Forward PE Ratio | -- |
Price/Book | 1.31 |
Price/Sales | 0.62 |
Price/Free Cash Flow | 23.11 |
Price/Owner Earnings | 18.25 |
Payout Ratio % | 0.30 |
Revenue (TTM) HK$ M | 83,483.00 |
EPS (TTM) HK$ | 2.74 |
Beneish M-Score | -2.33 |
10-y EBITDA Growth Rate % | 14.70 |
5-y EBITDA Growth Rate % | 8.50 |
y-y EBITDA Growth Rate % | 1.30 |
EV-to-EBIT | 7.15 |
EV-to-EBITDA | 7.15 |
PEG | 0.90 |
Shares Outstanding M | 1,625.79 |
Net Margin (%) | 5.34 |
Operating Margin % | 6.47 |
Pre-tax Margin (%) | 6.78 |
Quick Ratio | 1.35 |
Current Ratio | 1.64 |
ROA % (ttm) | 5.42 |
ROE % (ttm) | 11.79 |
ROIC % (ttm) | 12.25 |
Dividend Yield % | 3.90 |
Altman Z-Score | 2.64 |
HKSE:00874 Number of Guru Trades
HKSE:00874 Volume of Guru Trades
Gurus Latest Trades with HKSE:00874
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
HKSE:00874 is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Insider Transactions
No Available Data